Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

April 3, 2019

Study Completion Date

April 3, 2019

Conditions

Bacterial Infections

Interventions

DRUG

Dalbavancin

Trial Locations (5)

Duke Medical Center, Durham

University of Louisville, Louisville

Children's Mercy Kansas City, Kansas City

Mary Birch Hospital for Women and Newborns, San Diego

University of California, San Diego, San Diego